Credits: Health and me
What if your body could feel decades younger—just by tweaking how you live every day? A London longevity doctor who has done exactly that, by "hacking" her lifestyle and habits. Successfully reversing her biological age by 30 years.
In a time when longevity and vigor of youth are the center of health discussions, the life of Dr. Alka Patel serves as an inspiring testament to lifestyle medicine and individualised health optimisation. At the age of 53, Dr. Patel disobeys traditional ageing — stating that her biological age is more like 23. That this incredible change is not a matter of making up wishes but a science-based process based on facts, order, and a complete lifestyle transformation.
Chronological age—the years since birth—is only half the picture when it comes to ageing and health. Biological age, however, is the actual functional condition of our cells, tissues, and organs. A person's biological age may be younger or older than his or her chronological age based on lifestyle, genetics, environment, and overall health. For Dr. Patel, that was moving away from simply tallying years and thinking about how well her body was working at a cellular level. Her brain, heart, and skin now function as if she were three decades younger, rewriting the dictionary definition of 'ageing'.
Dr. Patel's quest to turn her biological clock around started under dire conditions. At 39, she hit a terrible health crisis brought on by burnout—an all-too-familiar yet too-often-neglected condition in stressful careers such as medicine. Worn down by round-the-clock work pressures and caregiving duties, her body started to give way, landing her with a fever of undetermined origin and the subsequent shutdown of critical organs.
Hospitalized and with the uncertainty of her survival, Dr. Patel was operated on, resulting in both physical wounds and a deep wake-up call. Faced with mortality, it altered her outlook, triggering a resolve to regain her health and longevity not only for herself but also for others who were going through similar battles.
Throwing off reactive, symptom-focused medicine, Dr. Patel implemented an in-depth 'Foundational, Functional, Focal' health optimisation plan that combined her medical training with a twenty-first-century, data-informed approach. She started by creating a strong foundation—optimising nutrition, sleep, movement, and stress management. Next, she progressed to functional diagnostics, gauging hormone levels, nutrient inadequacies, inflammation, and toxin burden through exhaustive testing. Lastly, she embraced a focal methodology, leveraging these points of data to establish specific health objectives, such as enhanced cognitive acuity and cardiovascular wellness.
This tiered, holistic approach not only changed the way Dr. Patel lived but also the way she perceived her body. Wearable technology such as Continuous Glucose Monitors (CGMs) and sleep trackers became essential utilities in her arsenal for health, empowering her to make intelligent, real-time choices—translating data into functional strategies.
Prior to her health change, Dr. Patel's life was a revolving cycle of chaos. Juggling a high-powered medical career, mother of three, and personal mission to 'do it all,' she consistently gave up sleep and balanced diet, burning through convenience foods and reactive coping strategies. The ongoing stress and inconsistent habits kept her in an ongoing state of 'firefighting' instead of 'fireproofing' her health.
Secrets Of A Longer, Healthier Life
Now, her day-to-day life reflects intentional decisions and micro-movements—tiny but potent interventions like walking outside into sunshine for a minute and gratitude practice, focusing on protein and fiber meals, and incorporating movement even in the most ordinary moments such as brushing her teeth. This rigorous routine has rewired her physiology and mindset, making her more resilient and vibrant.
Dr. Patel's longevity strategy goes beyond typical recommendations and gets into biohacking, but from a scientific perspective. Her regimen involves activities such as intermittent fasting—occasionally water-only fasts tracked by glucose sensors for safety, occasionally 'fasting mimicking diets' that still stimulate cellular regeneration pathways. Regular saunas help detoxification and cellular function, and marathon running and intermittent silence retreats push body and mind in ways that build resilience through calibrated discomfort.
In spite of peer skepticism on occasion based in conventional medical paradigms oriented toward disease treatment instead of proactive health optimisation, Dr. Patel is assured of the value of 'doctor-guided biohacking.' She is convinced that the complexity of the body requires expert guidance to safely and effectively set biological boundaries.
One of the key messages that Dr. Patel communicates is the paramount need for personalised approaches to health. A one-size-fits-all model does not exist for ageing or longevity. Rather, learning about one's individualised metabolic profile—via in-depth testing of more than 150 biomarkers—is what makes it possible to precision-target interventions. A case in point is fixing sleep problems by examining body temperature and lifestyle habits, as shown by a client who fixed sleep by modifying evening exercise habits and fasting windows.
These personalized strategies surpass blanket advice or blind supplementation. Though supplements such as magnesium or vitamin C can be beneficial to one's health, they are only beneficial when prescribed according to individual weaknesses or imbalance.
Dr. Patel promotes the principle of hormetic stress—safely exposing oneself to gentle stressors that stimulate the body's survival responses, boosting resilience and regeneration. Intermittent fasting, breathing exercises, cryotherapy (cold exposure) and heat therapy, in addition to creating physical resilience, also boost cognitive function and emotional equilibrium. This way of thinking redirects pain rather than a liability but as an accelerator for growth and longevity.
For Dr. Patel, it isn't just a matter of living longer but healthier for longer—of maximizing healthspan, that phase of life spent in good health and autonomy, rather than merely lifespan. The dread is not ageing, then, but losing energy and autonomy. Her contention that ageing is a choice encapsulates an empowering ethos: time may move inexorably, but how our bodies react and adapt is under our command to a large extent.
This philosophy is evident in her own vigor—daylong consistent energy, clearer thinking, and an appreciation for renewed strength and beauty. The tests, such as long marathons and fasting discomfort, are accepted as part of a journey of self-discovery and mastery that unfolds throughout an entire lifetime.
Dr. Patel accompanies these developments with reservations, highlighting the necessity of medical supervision and individualized safety. The enthusiasm over such breakthroughs promises a world in which reversal of biological age is possible, but she reminds us that fundamental lifestyle changes constitute the cornerstone of long-term health.
Dr. Alka Patel's tale is more than an individual health victory; it is a harbinger for anyone hoping to restore youthful vitality through evidence-based, tailored lifestyle medicine. Her journey from the brink of lethal burnout to thriving with a biological age three decades younger is a testament that ageing is not a resigned destiny but an engaged, dynamic process that can be shaped dramatically by wise decisions.
Credits: Canva
While AIDS-related deaths have dropped to their lowest since 2004, the world is still battling against HIV. Amid all this, a United Nations statement highlights the serious global health issue that it has become. Despite the years of progress and scientific breakthroughs, the disease still claims one life every minute, and continues to the global toll of the epidemic.
More than 30 million people across the world at this moment are receiving life saving antiretroviral treatment. As per the UN Under Secretary-General Amina Mohammed, this is a testament to the power of multilateral action. Speaking at the UN General Assembly’s review of the global AIDS response, she called it a “clear example of multilateral success.”
However behind these figures, is also a fragile system that Mohammed too stressed upon. "Global commitment is fading, funding is falling, and HIV services are being disrupted." This could undo years of hard work. The Health and Me has previously reported that the United States government also abrupted halted funding for a seminal mRNA-based HIV vaccine study, just days before its scheduled start in March 2025.
Health and Me also reported on the US' plan to freeze all foreign assistance, along with the UNAIDS, which could become a global threat for HIV cases. The UNAIDS takes up less than 1% of the overall US budget and since Trump's re-election, audits for cost-cutting and executive orders, especially in the healthcare sector has changed the shape of how aid worked before.
UNAIDS Executive Director Winnie Byanyima noted that HIV infections have in fact decreased in the recent years. In 2023, 1.3 million new cases were recorded, which is a 60% decline since the virus peaked in 1995. However, with this abrupt cut off in funding, it has created a situation of "panic, fear and confusion" in many of the African countries which are hit hardest by AIDS.
“We cannot let short-term cuts destroy long-term progress,” Mohammed urged. She called for the funding crisis to be treated with urgency and seriousness. In many low- and middle-income countries, healthcare budgets are being squeezed by the burden of debt servicing. In sub-Saharan Africa, half of the countries spend more on debt payments than on healthcare.
To counter this imbalance, Mohammed advocated for debt relief, global tax reform, and stronger international collaboration. She also emphasized the need for national governments to show stronger leadership and invest in sustainable HIV financing models.
Beyond finances, Mohammed pointed to another major challenge: attacks on human rights. Marginalised groups—including LGBTQ+ individuals, sex workers, and people who use drugs—are often criminalised or face violence, hate speech, and stigma. Such punitive laws and attitudes only push people further away from testing, treatment, and prevention services.
“Protecting health means protecting human rights,” Mohammed stated, urging nations to remove discriminatory laws and support inclusive healthcare services. She also highlighted the role of community-led organizations, many of which are now facing defunding. These groups are often closest to at-risk populations and play a crucial role in delivering services, especially in hard-to-reach areas.
While the global community has made historic progress, the fight against AIDS is far from over. “The end of AIDS is not a mystery,” said Mohammed. “But success is not guaranteed.” She reiterated that with the right investments, policies, and leadership, eliminating AIDS by 2030 is still within reach—but only if the world “keeps up the fight.”
(Credit-Canva)
Having a family pet is a favorable idea considered by many. While parents of young children are worried about bacteria and germs being an issue, there are also other factors to consider. Many studies, like ‘The Power of Pets’ published in the News in Health, have shown how pets play a very important role in a child’s development. They explain how pets have been observed to lower cortisol levels as well as lower blood pressure. They also pointed out that studies have found pets to lower the feeling of loneliness, increase social support as well, and boost your mood.
A new study shows a favorable result for families who wish to have pets, especially dogs, as they not only passively help your kid’s health, but they can also have an active effect on them.
New research suggests that having a family dog might lower a baby's chances of getting eczema later in life. This study, published on June 4th in the journal Allergy, indicates that being around dogs could actually change how a child's genes react to eczema, by calming down skin inflammation.
Researchers explained that while we know genes play a role in eczema risk and that dogs might be protective, this is the first study to show how this happens at a very basic level. Eczema happens when something irritates the skin, causing it to become dry, itchy, and inflamed. We know some people are born more likely to get eczema, but exactly how their genes and their surroundings work together to either increase or decrease this risk hasn't been clear.
The researchers conducted a comprehensive analysis of data from 16 previously conducted studies. Their goal was to identify interactions between 24 specific genetic variants already known to be linked to eczema and a list of 18 environmental factors that could potentially influence a baby's susceptibility to the condition later in life.
which included over 25,000 people, narrowed down the environmental factors to seven key ones: antibiotic use, owning a cat, owning a dog, breastfeeding, having an older sibling, smoking, and hygiene.
The team then applied these findings to data from another 254,000 people to see which genes and environmental factors had the biggest impact on eczema risk. This second look found that a baby's exposure to dogs affects the interleukin-7 gene. This gene is involved in making a type of immune protein that helps control inflammation. Lab tests showed that being around dogs interacts with a gene variation that might otherwise cause eczema, essentially reducing skin inflammation by changing how interleukin-7 proteins work in human skin cells.
The experts explained that their research aims to answer common questions parents ask, like "Why does my child have eczema?" and "What can I do to protect my baby?" While these findings are exciting, the researchers also stressed that more studies are needed to confirm what they found in the lab and to better understand exactly how dogs might affect human genes in this way. Researchers believes these findings give us a chance to tackle the rise of allergic diseases and protect future generations.
Credits: Canva
More American teens are being prescribed Wegovy, a weight-loss drug that mimics a hormone to regulate appetite, as doctors and families grow more comfortable using medications to treat obesity in adolescents. While this signals growing acceptance of medical tools to tackle a complex and often lifelong health issue, experts caution that challenges around access, affordability, and long-term safety persist.
Wegovy was approved by the U.S. Food and Drug Administration (FDA) in late 2022 for children aged 12 and older who are living with obesity. Since then, prescriptions have surged. According to health data company Truveta, which reviewed medical records from 30 U.S. health systems, prescriptions for Wegovy among teens jumped by 50% in 2024—rising from 9.9 per 100,000 adolescents in 2023 to 14.8 per 100,000 in 2024. The first quarter of 2025 showed another increase, with the rate reaching 17.3 per 100,000.
But these numbers are still small compared to the scale of the issue. Government data shows that 8 million U.S. teens—about 23% of those aged 12 to 19—are living with obesity, a number that has more than quadrupled since 1980. The condition raises long-term risks such as type 2 diabetes, heart disease, and liver disease.
“It’s promising that more young people are using these medications, but it’s still a very small percentage of patients with severe obesity that are getting access to them,” said Dr. Cate Varney, an obesity medicine specialist at the University of Virginia Health System, in an interview with NBC News. “When lifestyle changes alone are insufficient, we need these additional tools.”
The American Academy of Pediatrics (AAP) updated its guidelines in 2023 to recommend that doctors consider GLP-1 medications, like Wegovy, for children 12 and older with obesity. GLP-1 drugs mimic the effects of a hormone that controls hunger and food intake. However, only Wegovy is FDA-approved for adolescents. Others, such as Ozempic and Zepbound, are not approved for teen weight loss, though they are being studied for future use.
Despite the increased use, concerns linger. Experts point out that there is limited long-term data on how these medications may affect a developing adolescent’s body. “These medications are likely to be needed for a very long time to maintain weight,” said Dr. Robert Siegel of Cincinnati Children’s Hospital. “And we only have a relatively short-term experience with them.”
Insurance coverage also presents a significant barrier. Many health plans do not cover weight-loss drugs for teens and often deny coverage for complementary care such as visits to dietitians or behavioral counseling. At Nemours Children’s Hospital in Delaware, about 25% of teens in one obesity treatment program were prescribed Wegovy or a similar drug last year—almost double the number from 2023. Still, many could not access the drug due to insurance or concerns about side effects.
Novo Nordisk, the maker of Wegovy, claims its trials found no negative effects on puberty or growth. Eli Lilly, which produces Zepbound, is conducting its own studies in teens and so far reports no adverse effects on growth or metabolism.
“We are confident in the proven safety and efficacy of our GLP-1 medicines,” Novo Nordisk said in a statement. Still, both researchers and government officials, including U.S. Health Secretary Robert F. Kennedy Jr., stress the need for long-term studies to fully understand the impact of using these medications in young people.
© 2024 Bennett, Coleman & Company Limited